The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge
- PMID: 3265385
- DOI: 10.1007/BF00555505
The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge
Abstract
To evaluate the specificity of the lymphocyte transformation test (LTT) in the diagnosis of drug allergy we studied over 71 days an atopic woman with a past history of frequent adverse reactions to pyrazolone drugs. Rechallenge with the incriminated substances aminophenazone (aminopyrine) and propyphenazone was carried out on Days 11 and 31 respectively. An immediate type of hypersensitivity reaction was seen after 100 mg aminophenazone, while 100 mg of propyphanozone led to a serum sickness-like syndrome. We found two specifically sensitized lymphocyte populations using either the pure substance or sera containing metabolite in cell cultures. Stimulatory responses with indices ranging between 3 and 6 were seen 3-4 days after exposure, and the tests remained positive in both instances for 3-4 weeks. Specific sensitization was proven by positive skin tests and by a small but distinct lymphocyte proliferative response before challenge. Several lymphocyte function tests were performed over a period of 53 days and revealed a large fall in pokeweed mitogen-induced immunoglobulin synthesis and an increase in suppressor cell activity after rechallenge with aminophenazone. We conclude that the proliferative response observed in the presence of the offending drug is due to the activation of T memory cells and therefore highly suggestive of a true allergic reaction.
Similar articles
-
IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone.J Allergy Clin Immunol. 2003 Apr;111(4):882-8. doi: 10.1067/mai.2003.163. J Allergy Clin Immunol. 2003. PMID: 12704373
-
The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity.Clin Exp Allergy. 1997 Feb;27(2):175-81. Clin Exp Allergy. 1997. PMID: 9061217
-
Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in vitro testing.Allergy Asthma Proc. 1999 Nov-Dec;20(6):347-52. doi: 10.2500/108854199778251799. Allergy Asthma Proc. 1999. PMID: 10624489
-
Drug hypersensitivities: which room for biological tests?Eur Ann Allergy Clin Immunol. 2005 Jun;37(6):230-5. Eur Ann Allergy Clin Immunol. 2005. PMID: 16156402 Review.
-
Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines.Toxicology. 2005 Apr 15;209(2):217-20. doi: 10.1016/j.tox.2004.12.026. Toxicology. 2005. PMID: 15767039 Review.
Cited by
-
Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease.Eur J Clin Pharmacol. 2009 Dec;65(12):1195-201. doi: 10.1007/s00228-009-0705-9. Eur J Clin Pharmacol. 2009. PMID: 19641912
-
Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells.Int J Nanomedicine. 2012;7:4571-80. doi: 10.2147/IJN.S33773. Epub 2012 Aug 20. Int J Nanomedicine. 2012. PMID: 22942641 Free PMC article.
-
Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens.Clin Exp Immunol. 2003 Oct;134(1):78-85. doi: 10.1046/j.1365-2249.2003.02265.x. Clin Exp Immunol. 2003. PMID: 12974758 Free PMC article.
-
Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).Thorax. 1989 Apr;44(4):307-9. doi: 10.1136/thx.44.4.307. Thorax. 1989. PMID: 2763233 Free PMC article.
-
The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes.Eur J Clin Pharmacol. 1992;42(6):629-33. doi: 10.1007/BF00265927. Eur J Clin Pharmacol. 1992. PMID: 1623903
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous